Prazosin-Related Reductions in Daily Craving Mediate Treatment-Related Daily Alcohol Use Outcomes in Alcohol Use Disorder

Stephanie Wemm, Rachel Hart, Gretchen Hermes, Zachary Harvanek, Rajita Sinha · 2026

Read Prazosin-Related Reductions in Daily Craving Mediate Treatment-Related Daily Alcohol Use Outcomes in Alcohol Use Disorder by Stephanie Wemm, Rachel Hart, Gretchen Hermes, Zachary Harvanek, Rajita Sinha (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13452975.txt.

Description

Stephanie Wemm, Rachel Hart, Gretchen Hermes, Zachary Harvanek, and Rajita Sinha ask whether the drug prazosin cuts drinking by first cutting craving. Their 2026 study sits inside a 12 week trial of prazosin against placebo for alcohol use disorder, with 52 people on the drug and 45 on placebo. Daily phone surveys tracked each person's craving and drinking, adding up to 4,289 daily reports.

Prazosin lowered daily craving, while placebo did not show the same drop. On days after craving fell, those on prazosin drank less the next day, a link that did not hold for the placebo group. The craving path explained about two thirds of the drug group's drop in drinking, against about a quarter for placebo. The authors read the result as proof that craving relief is the engine of the drug's effect.

Catalog record

CREATORStephanie Wemm, Rachel Hart, Gretchen Hermes, Zachary Harvanek, Rajita Sinha
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43342
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13452975

Browse the full library · About the Tower of Babel